Opus Genetics (IRD) Cash from Investing Activities (QoQ) (2010 - 2019)
Opus Genetics (IRD) Cash from Investing Activities (QoQ) (2010 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -104.12% |
| Sep 30, 2019 | 0.21% |
| Jun 30, 2019 | 150.78% |
| Mar 31, 2019 | -394.76% |
| Dec 31, 2018 | -45.42% |
| Sep 30, 2018 | 12.79% |
| Jun 30, 2018 | 8.39% |
| Mar 31, 2018 | 197.87% |
| Dec 31, 2017 | -202.21% |
| Sep 30, 2017 | 129.91% |
| Jun 30, 2017 | -1,510.17% |
| Mar 31, 2017 | -84.82% |
| Dec 31, 2016 | 345.47% |
| Sep 30, 2016 | -176.96% |
| Jun 30, 2016 | 423.23% |
| Mar 31, 2016 | 82.08% |
| Dec 31, 2015 | -161.46% |
| Sep 30, 2015 | 164.08% |
| Jun 30, 2015 | -37.79% |
| Mar 31, 2015 | 289.66% |